Get the Stockscreener App
9.09
1.56%
0.14
After Hours:
9.09
Cvrx Inc stock is traded at $9.09, with a volume of 142.76K.
It is up +1.56% in the last 24 hours and up +15.50% over the past month.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
See More
Previous Close:
$8.95
Open:
$9.05
24h Volume:
142.76K
Relative Volume:
0.59
Market Cap:
$237.72M
Revenue:
$47.26M
Net Income/Loss:
$-58.48M
P/E Ratio:
-3.3606
EPS:
-2.7049
Net Cash Flow:
$-40.45M
1W Performance:
+4.12%
1M Performance:
+15.50%
6M Performance:
+45.91%
1Y Performance:
+21.52%
1-Day Range:
$8.50
$9.35
1-Week Range:
$8.50
$9.35
52-Week Range:
$4.2993
$18.55
Cvrx Inc Stock (CVRX) Company Profile
Name
Cvrx Inc
Sector
Industry
Phone
(763) 416-2850
Address
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Compare CVRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
9.09 | 233.35M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-09-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-14-25 | Upgrade | William Blair | Mkt Perform → Outperform |
| Sep-10-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-11-24 | Reiterated | Lake Street | Buy |
| May-01-24 | Resumed | Craig Hallum | Buy |
| May-01-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-01-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-31-23 | Initiated | Lake Street | Buy |
| Jul-18-22 | Initiated | Craig Hallum | Buy |
| Jul-26-21 | Initiated | Canaccord Genuity | Buy |
| Jul-26-21 | Initiated | Piper Sandler | Overweight |
| Jul-26-21 | Initiated | William Blair | Outperform |
View All
Cvrx Inc Stock (CVRX) Latest News
Will CVRX bounce back from current support2025 Year in Review & Stock Portfolio Risk Control - newser.com
How to integrate CVRX into portfolio analysis tools2025 Geopolitical Influence & Proven Capital Preservation Methods - newser.com
How to manage a losing position in CVRXJuly 2025 Macro Moves & Capital Protection Trading Alerts - newser.com
Applying sector rotation models to CVRx Inc.Market Activity Report & Long-Term Safe Investment Plans - newser.com
How sentiment analysis helps forecast CVRXCPI Data & Long-Term Growth Plans - newser.com
Is CVRX building a consolidation baseJuly 2025 EndofMonth & Weekly Top Gainers Alerts - newser.com
What recovery options are there for CVRXJuly 2025 Intraday Action & Daily Volume Surge Signals - newser.com
Is CVRX stock trading at a premium valuationMarket Performance Recap & High Accuracy Swing Entry Alerts - newser.com
What MACD and RSI say about CVRx Inc.July 2025 Earnings & Verified High Yield Trade Plans - newser.com
How to monitor CVRx Inc. with trend dashboards2025 Market Overview & Smart Investment Allocation Insights - newser.com
CVRx upgraded by William Blair to outperform - MSN
Predicting CVRx Inc. trend using moving averagesJuly 2025 Pullbacks & Capital Efficient Trade Techniques - newser.com
What the charts say about CVRX today2025 Investor Takeaways & Short-Term Trading Alerts - newser.com
Is CVRx Inc. still worth holding after the dipWeekly Gains Summary & Free Technical Pattern Based Buy Signals - newser.com
Weiss Ratings Reaffirms Sell (D-) Rating for CVRx (NASDAQ:CVRX) - MarketBeat
Best data tools to analyze CVRX stockJuly 2025 Recap & Reliable Entry Point Trade Alerts - newser.com
Should you hold or exit CVRX now2025 Risk Factors & Free Safe Entry Trade Signal Reports - newser.com
What machine learning models say about CVRx Inc.Market Performance Summary & AI Powered Market Entry Ideas - newser.com
Smart tools for monitoring CVRX’s price actionJuly 2025 Chart Watch & Fast Entry High Yield Stock Tips - newser.com
CVRx, Inc. (NASDAQ:CVRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Tick level data insight on CVRx Inc. volatilityPortfolio Value Report & Long Hold Capital Preservation Tips - newser.com
Sentiment analysis tools applied to CVRXBreakout Watch & Real-Time Chart Pattern Alerts - newser.com
Does CVRX qualify in momentum factor screeningJuly 2025 EndofMonth & Risk Controlled Daily Trade Plans - newser.com
Real time scanner hits for CVRX explainedQuarterly Risk Review & Safe Capital Growth Stock Tips - newser.com
Is a relief rally coming for CVRx Inc. holders2025 EndofYear Setup & Proven Capital Preservation Methods - newser.com
Can CVRx Inc. stock resist market sell offsJuly 2025 Sentiment & Verified Momentum Watchlists - newser.com
$CVRX stock is up 11% today. Here's what we see in our data. - Quiver Quantitative
Long term hold vs stop loss in CVRXJuly 2025 Momentum & AI Powered Buy and Sell Recommendations - newser.com
How to build a dashboard for CVRX stockGold Moves & High Yield Equity Trading Tips - newser.com
Visualizing CVRX stock with heatmapsQuarterly Earnings Summary & Weekly Return Optimization Alerts - newser.com
Applying Wyckoff theory to CVRX stockRate Cut & AI Optimized Trading Strategy Guides - newser.com
Cvrx Inc Stock (CVRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cvrx Inc Stock (CVRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Nielsen Kirk G. | Director |
May 13 '25 |
Buy |
5.29 |
101,413 |
536,313 |
1,837,968 |
| Nielsen Kirk G. | Director |
May 14 '25 |
Buy |
5.23 |
61,200 |
320,364 |
1,899,168 |
| Nielsen Kirk G. | Director |
May 12 '25 |
Buy |
4.79 |
25,200 |
120,670 |
1,736,555 |
| Jain Mudit K. | Director |
May 12 '25 |
Buy |
4.66 |
1,500 |
6,986 |
4,900 |
| Jain Mudit K. | Director |
May 13 '25 |
Buy |
5.26 |
150 |
789 |
5,050 |
| Hykes Kevin | PRES & CEO |
May 12 '25 |
Buy |
4.84 |
5,000 |
24,200 |
133,000 |
0.01%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):